BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Diabetes News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Sanofi Wins FDA Approval for New Insulin Drug Toujeo     2/26/2015
Shares Surge as Novo Nordisk A/S Shows Off Positive Trial Data for Oral Insulin     2/23/2015
Bayer AG May Have a Buyer for Diabetes Biz     2/23/2015
Regeneron's Eylea Beats Genentech in Rare Face Off Over Some Vision Loss Cases     2/20/2015
Pfizer Failed in 2012 but Now Sanofi Will Take a Stab at a Fully Remote Diabetes Trial     2/12/2015
Stock Falls as Columnist Accuses Isis Pharmaceuticals, Inc. of Time-Shifting Diabetes Drug Trial to Embellish Data     2/4/2015
Eli Lilly, Adocia Ink $570 Million Pact To Develop Fast-Acting Insulin     12/19/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Bayer AG Continues Efforts To Sell Diabetes Device Unit     11/25/2014
Best Value In Biotech? Actavis, Says UBS     11/17/2014
DiaMedica Inc. Announces Top-Line Results Of Phase 2a Clinical Trial Of DM199 For Type 2 Diabetes     11/17/2014
Servier Bets $1 Billion+ On Intarcia Therapeutics, Inc.'s Diabetes Device     11/13/2014
Novo Nordisk A/S More Mindful On Timing Of U.S. Tresiba Launch     10/30/2014
Ampio Pharmaceuticals, Inc. Could Have A Blockbuster Fourth Quarter, Says Citi     10/29/2014
Eli Lilly, Boehringer Mannheim Corporation Revise Terms Of Diabetes Drugs Alliance     10/29/2014
 Featured Stories
First World War Explosive Could Reverse Diabetes, Yale University Study     2/27/2015
Benefit Of Exercise Magnified To Prevent Heart Condition, University of Virginia Reveals     2/25/2015
Lack Of Vitamin D Linked To Higher Diabetes Risk, Universidad de Málaga Study     2/24/2015
Diabetes, Depression Boost Dementia Risk, University College London Study     2/23/2015
Flame Retardants Used In Couches May Cause Metabolic, Liver Problems, University of New Hampshire Reveals     2/23/2015
Loss Of Sleep Leads To Diabetes, University of Chicago Study Reveals     2/19/2015
Kids With Type 1 Diabetes At Risk For Mental Health Problems, Karolinska Institute Reveals     2/19/2015
Type 2 Diabetes May Boost Alzheimer's Risk, Uppsala Universitet Study     2/19/2015
Taking Too Much Folic Acid May Put Daughters At Risk For Diabetes, Obesity, University of Porto Study     2/11/2015
Novel "Smart" Insulin Can Sense Blood Sugar Levels, University of Utah Study     2/10/2015
Yale University School Of Medicine Team Identifies Link Between Inflammation And Type 2 Diabetes     2/10/2015
Broad Institute Researchers Find Link Between Microbiome, Type 1 Diabetes     2/9/2015
Insulin-Decreasing Hormone Discovered In Flies, Humans, Stanford University School of Medicine Reveals     2/5/2015
Metformin May Lower Lung Cancer Risk In Diabetics, Kaiser Permanente Division Of Research Study     2/3/2015
Added Fructose Fuels Type 2 Diabetes, Saint Luke's Mid America Heart Institute Study     1/30/2015
 More News
Sanofi (SAN.PA) Receives FDA Approval Of Once-Daily Basal Insulin Toujeo     2/26/2015
Novo Nordisk A/S (NVO) Announces Positive Results For Phase 2 Trial With Oral Semaglutide In People With Type 2 Diabetes     2/20/2015
Regeneron (REGN) Release: NIH-Sponsored Comparative Effectiveness Trial In Diabetic Macular Edema Shows EYLEA (Aflibercept) Injection Demonstrated Significantly Greater Gains In Visual Acuity Than Both Bevacizumab And Ranibizumab     2/19/2015
PharmaCyte Biotech Diabetes Consortium Member Publishes Review Article On Use Of Genetic Engineering To Treat Diabetes     2/13/2015
Janssen Research & Development Sets A Course To Intercept Type 1 Diabetes Together With JDRF     2/12/2015
Pharmacyte Biotech's International Diabetes Consortium Sets Path Forward To Develop Novel Treatment For Diabetes     2/10/2015
Hua Medicine Reports Single Oral Drug Controls Diabetes For 24 Hours     2/9/2015
MicroBiome Therapeutics LLC Receives Notice Of Allowance For U.S. Patent Covering Glyceollin As A Treatment For Diabetes And Obesity     2/9/2015
Isis Pharmaceuticals, Inc. (ISIS)'s Diabetes Drug Effective in Phase 2 Study     2/3/2015
Sanofi (SAN.PA) And MannKind Corporation (MNKD) Announce Afrezza®, The Only Inhaled Insulin, Now Available In The U.S.     2/3/2015
Pharmacyte Biotech Initiates First Preclinical Study Of Its Encapsulated Cell Product For Novel Treatment Of Diabetes     2/2/2015
Endexx Announces Positive Results Of Initial Diabetic Neuropathy Patient Study     1/29/2015
The Journal Diabetes Publishes Pre-Clinical Data On Cortendo’s Novel Diabetes Treatment, BP-2001     1/28/2015
American Association of Diabetes Educators Release: Survey Shows Many People Living With Diabetes Are Uncertain About How To Properly Manage Hypoglycemia     1/20/2015
MaRS Innovation Announces Collaboration With Johnson & Johnson (JNJ) Innovation And Janssen To Advance Cardiac, Diabetes And Depression Technologies     1/12/2015